4//SEC Filing
Galena Biopharma, Inc. 4
Accession 0001250853-13-000078
$SLSCIK 0001390478operating
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 5:52 PM ET
Size
5.0 KB
Accession
0001250853-13-000078
Insider Transaction Report
Form 4
SCHWARTZ MARK W.
EVP Chief Operating Officer
Transactions
- Award
Common Stock
2013-06-04+26,110→ 488,798 total
Footnotes (1)
- [F1]The shares acquired were issued for the account of the reporting person at a value of $2.60 per share in payment of contingent value rights held by the reporting person.
Documents
Issuer
Galena Biopharma, Inc.
CIK 0001390478
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001390478
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 5:52 PM ET
- Size
- 5.0 KB